Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (51-60 of 784) with videos related to

Pageof 79
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patientsChristoph Wanner, Thomas Metzger
Blood Purification|September 11, 2002
Uremia-specific alterations in lipid metabolismChristoph Wanner, Vera Krane
Clinical Kidney Journal|February 13, 2019
Will the FAbry STabilization indEX make its way to everyday clinical practice?Tereza Cairns, Christoph Wanner
Nature Clinical Practice. Nephrology|August 26, 2006
At which stage of chronic kidney disease should dyslipidemia be treated?Vera Krane, Christoph Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2021
Precision medicine in diabetic nephropathy and chronic kidney diseaseDanilo Fliser, Christoph Wanner
Diabetologia|August 23, 2018
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseasesChristoph Wanner, Nikolaus Marx
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?Vera Krane, Christoph Wanner
Journal of the American Society of Nephrology : JASN|October 10, 2008
Statin use prolongs patient survival after renal transplantationEberhard Ritz, Christoph Wanner
Kidney International|February 21, 2014
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patientChristoph Wanner, Marcello Tonelli,
Clinical Therapeutics|April 9, 2008
Foreword. The 8th Annual European Round Table on Fabry DiseaseChristoph Wanner, Uma Ramaswami
Pageof 79

Showing results (51-60 of 784) with videos related to

Sort By:
Pageof 79
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patientsChristoph Wanner, Thomas Metzger
Blood Purification|September 11, 2002
Uremia-specific alterations in lipid metabolismChristoph Wanner, Vera Krane
Clinical Kidney Journal|February 13, 2019
Will the FAbry STabilization indEX make its way to everyday clinical practice?Tereza Cairns, Christoph Wanner
Nature Clinical Practice. Nephrology|August 26, 2006
At which stage of chronic kidney disease should dyslipidemia be treated?Vera Krane, Christoph Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2021
Precision medicine in diabetic nephropathy and chronic kidney diseaseDanilo Fliser, Christoph Wanner
Diabetologia|August 23, 2018
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseasesChristoph Wanner, Nikolaus Marx
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?Vera Krane, Christoph Wanner
Journal of the American Society of Nephrology : JASN|October 10, 2008
Statin use prolongs patient survival after renal transplantationEberhard Ritz, Christoph Wanner
Kidney International|February 21, 2014
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patientChristoph Wanner, Marcello Tonelli,
Clinical Therapeutics|April 9, 2008
Foreword. The 8th Annual European Round Table on Fabry DiseaseChristoph Wanner, Uma Ramaswami
Pageof 79